On the Record · Nasus Pharma
Nasus Pharma competitors, on the record
The companies Nasus Pharma itself names as competitors in its annual reports, 2025, each with the sentence it appears in and the filing it came from.
Who Nasus Pharma names
| Company | Named in |
|---|---|
| ADAPT Pharma, Inc. | 2025 |
| Kaléo, Inc. | 2025 |
| Pfizer Inc. | 2025 |
| Teva Pharmaceuticals Ltd. | 2025 |
| Viatris Inc. | 2025 |
In its own words
ADAPT Pharma, Inc., Kaléo, Inc., Pfizer Inc., Teva Pharmaceuticals Ltd., Viatris Inc.
Word for word“The major market players within the intranasal drug market and our primary competitors in the United States and abroad include ADAPT Pharma, Inc., Teva Pharmaceuticals Ltd., Pfizer Inc., Viatris Inc., and Kaléo, Inc., among others.” 20-F for 2025
Read from Nasus Pharma’s annual reports (20-F for 2025) and the financial data it files with the SEC, as of 2026-03-25. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.